Strata Critical Medical Inc. Class A Common Stock
SRTAUnited States
5 filed reports · 270 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 950 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 611 | Dec 2025 |
Financial data
270 concepts · 1,561 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial264 concepts · 1,487 facts · Jun 2024 to Jun 2026
- Adjustments related to tax withholding for share based compensation11 · Jun 2024 to Jun 2026
- Adjustments to additional paid in capital share based compensation restricted stock units requisite service period recognition11 · Jun 2024 to Jun 2026
- Cash and cash equivalents at carrying value11 · Jun 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents11 · Jun 2024 to Jun 2026
- Comprehensive income net of tax11 · Jun 2024 to Jun 2026
- Cost of revenue (US GAAP)11 · Jun 2024 to Jun 2026
- Depreciation11 · Jun 2024 to Jun 2026
- Depreciation depletion and amortization11 · Jun 2024 to Jun 2026
- Fair value adjustment of warrants11 · Jun 2024 to Jun 2026
- Income tax expense benefit11 · Jun 2024 to Jun 2026
- Indemnity holdback related to sale of business11 · Dec 2024 to Jun 2026
- Interest income expense nonoperating net11 · Jun 2024 to Jun 2026
- Net income loss11 · Jun 2024 to Jun 2026
- Nonoperating income expense11 · Jun 2024 to Jun 2026
- Operating income loss11 · Jun 2024 to Jun 2026
- Other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent11 · Jun 2024 to Jun 2026
- Other comprehensive income loss net of tax portion attributable to parent11 · Jun 2024 to Jun 2026
- Restricted cash and cash equivalents11 · Jun 2024 to Jun 2026
- Revenue11 · Jun 2024 to Jun 2026
- Stockholders equity (US GAAP)11 · Jun 2024 to Jun 2026
- Stock issued during period value stock options exercised11 · Jun 2024 to Jun 2026
- Accretion amortization of discounts and premiums investments10 · Sep 2024 to Jun 2026
- Amortization of intangible assets10 · Sep 2024 to Jun 2026
- Capital expenditures incurred but not yet paid10 · Sep 2024 to Jun 2026
Segment5 concepts · 70 facts · Jun 2024 to Jun 2026
- Revenue34 · Jun 2024 to Jun 2026
- Cost of revenue (US GAAP)16 · Jun 2024 to Jun 2026
- Gross profit (US GAAP)12 · Dec 2024 to Jun 2026
- Adjusted selling, general and administrative expense4 · Jun 2024 to Jun 2025
- Total Segment Adjusted EBITDA4 · Jun 2024 to Jun 2025
Geography1 concepts · 4 facts · Jun 2024 to Jun 2025
- Revenue4 · Jun 2024 to Jun 2025
Segments
74 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments4 members · 70 facts
- Clinical30 · Dec 2024 to Jun 2026
- Logistics18 · Dec 2024 to Jun 2026
- Passenger12 · Jun 2024 to Jun 2025
- Medical10 · Jun 2024 to Jun 2025
Statement geographical2 members · 4 facts
- Non Us2 · Jun 2024 to Jun 2025
- US2 · Jun 2024 to Jun 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 4, 2026
- FY2026 Q1May 6, 2026
- FY2025 Q4Mar 3, 2026
- FY2025 Q3Nov 10, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.